Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development

Life Sciences(2021)10.1016/j.lfs.2021.119993Source: DataRank Database

Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development is a research paper published in Life Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.30)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Azure L. Yarbrough ORCID,Benjamin M. Ford ORCID,Lirit N. Franks,Alicja Urbaniak ORCID,Lori L. Hensley

Live enrichment

PubMed:34592231 PMC:PMC10395316 OpenAlex:https://openalex.org/W3203816540

National Institute on Drug Abuse

Grant: DA039143

National Institute of General Medical Sciences

Grant: P20 GM103429

NIDA NIH HHS

Grant: R01 DA039143

National Institutes of Health

Grant: 5R01DA039143-05

Synthetic Cannabinoid Toxicity: Role of Biotransformation

National Institutes of Health

Grant: 3P20GM103429-20S1

Understanding Hesitant Adopters

FWCI

0.30

Citation Percentile

0.6%

Citation Trend

2022

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10395316/pdf/nihms-1916810.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0024320521009802?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0024320521009802?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10395316

Fields of Study

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisHippo pathway signaling and YAP/TAZ0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Drug DevelopmentAntineoplastic AgentsBinding, CompetitiveCannabinoidsCytotoxinsHumansLigandsMorpholinesNaphthalenesSarcoma, EwingReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Cell Line, TumorBenzoxazines

Keywords

Cannabinoid receptorCannabinoidRadioligandReceptorCannabinoid receptor type 2ChemistryViability assayAdenylyl cyclaseCytotoxicityMolecular biologyBiochemistryBiologyCellAgonistIn vitroCell viabilityCannabinoid receptorsEwing SarcomaCannabidiolWin-55,212-2CannabinoidsCytotoxinsMorpholinesAntineoplastic AgentsSarcoma, EwingNaphthalenesLigandsBinding, CompetitiveBenzoxazinesReceptor, Cannabinoid, CB2Drug DevelopmentReceptor, Cannabinoid, CB1Cell Line, TumorHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being